We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group Inc. (UNH - Free Report) , the bellwether of health insurance companies, boasts of significant benefits of scale and diversification, which positions it well to drive growth in a dynamic market backdrop.
UnitedHealth stands apart from its peers as it has focused on growing the less regulated business that is the health services segment named as Optum. This health service segment is like a jewel in the crown for the company and is expected to make increasing contribution to the group’s overall revenues going forward.
The company has also exited on most of the public exchanges in a bid to save itself from losses occurring from business conducted on these exchanges.
UnitedHealth’s impressive results so far this year and strong guidance for 2017 point to growth. Improving commercial pricing, growing Medicare Advantage enrollment, Medicaid contract wins, stable medical costs and continued growth at Optum are likely to drive revenues.
UnitedHealth has a pretty good earnings track record with the company delivering positive earnings surprises in each of the last four quarters with an average surprise of 3.9%.
Earnings Beat: UnitedHealth beat earnings by 1.9%. Our consensus called for EPS of $2.07 and the company reported EPS of $2.11.
Revenues Beat: UnitedHealth posted revenues of $47.5 billion, compared to our consensus estimate of $46.8 billion and grew 9% year over year.
Key Stats: Revenues from UnitedHealthcare segment came in at $37.9 billion up 15.5% year over year while the other segment – Optum posted revenue of $22.2 billion up 1.4% year over year.
Total medical membership at the end of the reported quarter was 48.59 million up from 46.4 million in the year ago quarter.
Guidance for 2017 – UnitedHealth affirmed its 2017 guidance. It estimates revenues of $197 billion to $199 billion, net earnings of $8.75 to $9.05 per share, adjusted net earnings of $9.30 to $9.60 per share, and cash flows from operations of $11.5 billion to $12 billion.
UnitedHealth Group Incorporated Price and EPS Surprise
Check back later for our full write up on this UnitedHealth earnings report later!
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth 's (UNH) Q4 Earnings Beat, Affirms Guidance
UnitedHealth Group Inc. (UNH - Free Report) , the bellwether of health insurance companies, boasts of significant benefits of scale and diversification, which positions it well to drive growth in a dynamic market backdrop.
UnitedHealth stands apart from its peers as it has focused on growing the less regulated business that is the health services segment named as Optum. This health service segment is like a jewel in the crown for the company and is expected to make increasing contribution to the group’s overall revenues going forward.
The company has also exited on most of the public exchanges in a bid to save itself from losses occurring from business conducted on these exchanges.
UnitedHealth’s impressive results so far this year and strong guidance for 2017 point to growth. Improving commercial pricing, growing Medicare Advantage enrollment, Medicaid contract wins, stable medical costs and continued growth at Optum are likely to drive revenues.
UnitedHealth has a pretty good earnings track record with the company delivering positive earnings surprises in each of the last four quarters with an average surprise of 3.9%.
Currently, UnitedHealth has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here We have highlighted some of the key stats from this just-revealed announcement below:
Earnings Beat: UnitedHealth beat earnings by 1.9%. Our consensus called for EPS of $2.07 and the company reported EPS of $2.11.
Revenues Beat: UnitedHealth posted revenues of $47.5 billion, compared to our consensus estimate of $46.8 billion and grew 9% year over year.
Key Stats: Revenues from UnitedHealthcare segment came in at $37.9 billion up 15.5% year over year while the other segment – Optum posted revenue of $22.2 billion up 1.4% year over year.
Total medical membership at the end of the reported quarter was 48.59 million up from 46.4 million in the year ago quarter.
Guidance for 2017 – UnitedHealth affirmed its 2017 guidance. It estimates revenues of $197 billion to $199 billion, net earnings of $8.75 to $9.05 per share, adjusted net earnings of $9.30 to $9.60 per share, and cash flows from operations of $11.5 billion to $12 billion.
UnitedHealth Group Incorporated Price and EPS Surprise
UnitedHealth Group Incorporated Price and EPS Surprise | UnitedHealth Group Incorporated Quote
Check back later for our full write up on this UnitedHealth earnings report later!
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>